Clinical trial
Serum and Corporal Irisin Level and Its Correlation With Erectile Function in Diabetic Obese Patients
Opening soon · Not applicable · 0 countries · Registry ID NCT06696599
What this study is about
Obese and diabetic men constitute a huge fraction of ED patients. There is established relation between both obesity ,diabetes and ED through multiple neuroendocrine and vascular players . A limited number of serum biomarkers are available for ED with diabetic patients. These are biomarkers often used for endothelial dysfunction, inflammation and oxidative stress. Serum E-selectin, endothelial progenitor cell (EPC), endothelial micro particle (EMP), tumour necrosis factor / interleukin-10 (TNF-a / IL-10), nitric oxide (NO), MDA (malondialdehyde) and lipoprotein (a) are the most used biomarkers in this population.
Basic eligibility
Full registry criteria
Treatments and study arms
Serum and corporal irisin
measure serum and corporal irisin
Primary outcomes
Measurement serum and corporal irisin in diabetic patients with erectile dysfunction
Study locations
0 locations were listed when this page was built. The first 40 are shown.